J&J CEO Joaquin Duato told investors this week that the orthopedics spinoff would allow J&J to focus on faster-growing ...
Along with DelOrefice’s departure, BD reported preliminary fiscal fourth-quarter revenue that analysts said was below Wall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback